The 3 biggest threats to radiology
Radiology has long been an attractive field for physicians-in-training, with...Read more on AuntMinnie.comRelated Reading: Top 5 trends from RSNA 2015 in Chicago ARRS: 6 reasons to be optimistic about radiology New ACR CEO Thorwarth bullish on radiology's future How to take action against radiology threats: Part 2 How to take action against radiology threats: Part 1Comments: 10/3/2016 5:16:44 AMraduser1 Ezekiel Emanuel.....Ezekiel Emanuel.....hmmm........where have I heard that name before? Oh yeah, that's right. He is/was a leading architect and proponent of ObamaCare. The same guy whose prediction for the suc...
Source: AuntMinnie.com Headlines - October 3, 2016 Category: Radiology Source Type: news

How safe and effective are new drugs for stroke prevention?
(Mayo Clinic) For decades, warfarin was the only oral blood thinner available to reduce the risk of stroke for patients with atrial fibrillation. Warfarin use is cumbersome, because it requires ongoing blood test to monitor the effect and has numerous drug and food interaction. Now a number of non-vitamin K antagonist oral anticoagulant drugs are available for patients with atrial fibrillation and claim to revolutionize the care for patients with atrial fibrillation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 3, 2016 Category: Global & Universal Source Type: news

ENSURE-AF Trial Supports Edoxaban for Electrical Cardioversion
ROME — Results of the largest-ever randomized clinical trial of anticoagulation for electrical cardioversion of patients with nonvalvular atrial fibrillation demonstrate that edoxaban is a safe, effective, and convenient alternative to the standard strategy of enoxaparin as a bridge to warfarin. (Source: Caring for the Ages)
Source: Caring for the Ages - September 29, 2016 Category: Health Management Authors: Bruce Jancin Source Type: news

Concomitant Aspirin in Patients With Atrial Fibrillation Concomitant Aspirin in Patients With Atrial Fibrillation
Is aspirin safe to use in conjunction with rivaroxaban or warfarin therapy in patients with atrial fibrillation?American Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 29, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Rivaroxaban, Apixaban Associated With Lower Brain Bleed Risk Than Warfarin in NVAF Rivaroxaban, Apixaban Associated With Lower Brain Bleed Risk Than Warfarin in NVAF
Rivaroxaban and apixaban are associated with a lower risk of intracranial hemorrhage (ICH) than warfarin in patients with nonvalvular atrial fibrillation (NVAF), according to a new study.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 26, 2016 Category: Intensive Care Tags: Neurology & Neurosurgery News Source Type: news

Empiric warfarin adjustment cut drug-drug interactions with antimicrobials
BOSTON – A medication management strategy to minimize the effect of drug-drug interactions (DDIs) between warfarin and common antimicrobials resulted in significantly greater time within therapeutic range for anticoagulation, as well as a numerically smaller, but nonsignificant, number of bleeding... (Source: Skin and Allergy News)
Source: Skin and Allergy News - September 23, 2016 Category: Dermatology Source Type: news

Lower NOAC Doses Common in Asia Still Better Than Warfarin
(MedPage Today) -- Real-world data from Taiwan suggest advantage (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 20, 2016 Category: Cardiology Source Type: news

Read The Letter Hillary Clinton's Doctor Wrote About The Presidential Nominee's Health
Hillary Clinton’s doctor penned a letter Wednesday with more information about the Democratic presidential nominee’s health. The letter comes as Clinton recovers from a bout of pneumonia. Clinton’s physician, Dr. Lisa Bardack, said the presidential hopeful “is recovering well with antibiotics and rest.” Below, the full text of Dr. Bardack’s letter on Clinton’s health: This letter is a summary update on Hillary Rodham Clinton’s health since the release of my previous medical statement in July 2015. Mrs. Clinton has been seen by me regularly this year for routine car...
Source: Healthy Living - The Huffington Post - September 14, 2016 Category: Consumer Health News Source Type: news

Is Post-TAVR Triple Therapy Safe in Patients with Atrial Fibrillation?
Could triple therapy after TAVR in patients with AF and on warfarin be one therapy too many? Results reported at ESC, here. (Source: ConsultantLive)
Source: ConsultantLive - September 14, 2016 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news

Larger TAVR Valves May Predispose to Clot, But Will Warfarin Help? Larger TAVR Valves May Predispose to Clot, But Will Warfarin Help?
Warfarin alone or with antiplatelet therapy may protect against thrombosis after transcatheter aortic-valve replacement, but not everyone agrees there is enough support for anticoagulants yet.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 12, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

ENSURE-AF: Edoxaban Effective as Warfarin at AF Cardioversion ENSURE-AF: Edoxaban Effective as Warfarin at AF Cardioversion
"If you've got a patient on edoxaban coming in for cardioversion, do you need to switch him over to warfarin, or is it safe to carry on with edoxaban?" This trial says it is, says an expert observer.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 30, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

Results of trial into anticoagulants for cardioversion in atrial fibrillation patients published
Clinical trial finds edoxaban to be equally effective as current use of warfarin. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 30, 2016 Category: Science Source Type: news

Trial results for anticoagulants for cardioversion in AF patients published
(University of Birmingham) The results of the largest known clinical trial to investigate the use of anticoagulants prior and post cardioversion in atrial fibrillation patients, published in The Lancet, show that non-vitamin K antagonist oral anticoagulants could be equally as effective as the currently used warfarin. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 30, 2016 Category: Global & Universal Source Type: news

Rivaroxaban 'could be a safe treatment option for antiphospholipid syndrome'
The drug rivaroxaban could be an effective means of treating some patients with thromboticantiphospholipid syndrome, according to a new study. Led by University College London and funded byArthritis Research UK, the research has suggested that the drug - which works by inhibiting the formation of blood clots - could be a useful tool in the treatment of those with this serious condition, which affects approximately 15 per cent of patients withlupus and may also occur on its own. The danger of antiphospholipid syndrome Thrombotic antiphospholipid syndrome is classified as a rare condition, but is probably underdiagnosed. It ...
Source: Arthritis Research UK - August 30, 2016 Category: Rheumatology Source Type: news

New oral anticoagulants provide same stroke prevention as warfarin but cause less bleeding
The new oral anticoagulants provide the same stroke prevention as warfarin but cause less intracranial bleeding, reports an observational study in more than 43,000 patients. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 27, 2016 Category: Science Source Type: news

Initial data release of regular blood drip stain created by varying fall height, angle of impact and source dimension - Basu N, Bandyopadhyay SK.
The dataset developed consists of 108 blood drip stains developed with fresh porcine blood, blood admixed with different dosage of Warfarin and Heparin, respectively. For each particular blood type (i.e. fresh blood, blood admixed with Warfarin at differen... (Source: SafetyLit)
Source: SafetyLit - August 27, 2016 Category: Global & Universal Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

New oral anticoagulants provide same stroke prevention as warfarin but cause less bleeding
(European Society of Cardiology) The new oral anticoagulants provide the same stroke prevention as warfarin but cause less intracranial bleeding, reports an observational study in more than 43,000 patients presented at ESC Congress 2016 today by Dr. Laila Staerk, a research fellow at Herlev and Gentofte University Hospital, Denmark. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2016 Category: Global & Universal Source Type: news

Warfarin Alone May Be Adequate for AF Patients Undergoing TAVR Warfarin Alone May Be Adequate for AF Patients Undergoing TAVR
The addition of antiplatelet therapy to warfarin is not associated with fewer thrombotic events, but appears to increase the risk of bleeding in patients with atrial fibrillation (AF) who undergo transcatheter aortic valve replacement (TAVR), according to a multicenter study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 25, 2016 Category: Surgery Tags: Cardiology News Source Type: news

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin
MILPITAS, Calif., Aug. 25, 2016 -- (Healthcare Sales & Marketing Network) -- Armetheon, Inc., a specialty pharmaceutical company developing novel small molecule drugs for cardiovascular diseases, today announced results from its Phase 1 clinical trial eva... Biopharmaceuticals, Cardiology Armetheon, tecarfarin, warfarin, anticoagulant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 25, 2016 Category: Pharmaceuticals Source Type: news

Speculating About Candidate Health Is Mudslinging, Not Medicine
Hey everyone. How are you? Just checking in because this doozy of an election cycle is starting to show. We’re all a little punch drunk and some of us aren’t making much sense anymore.  Case in point? Dr. Drew Pinsky. The medical doctor and media personality went on KABC’s McIntyre in the Morning this week and made some unfounded statements about Hillary Clinton’s wellbeing, stating he was “gravely concerned” about the democratic nominee’s health and health care. Here’s the full clip: Pinsky is a board-certified internist. And his legitimate medical creden...
Source: Science - The Huffington Post - August 19, 2016 Category: Science Source Type: news

Aug 19 Cardiology News Aug 19 Cardiology News
PCSK9 drug pricing, medical adherence, warfarin stability, hs-troponin, brain protection during TAVR, and an FDA decision on a factor Xa antidote are discussed by Dr Mandrola in this week's podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 19, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

Arefa MD's Morning Report: Statin-SSRI Combination, Statins in CKD, Warfarin, Exercise Arefa MD's Morning Report: Statin-SSRI Combination, Statins in CKD, Warfarin, Exercise
Dr Arefa Cassoobhoy provides a quick rundown of this week's news on statins to augment SSRIs, statins in CKD, warfarin and INR stability, and exercise as prevention.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 19, 2016 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Blood Clots, Deep Vein Thrombosis and Pulmonary Embolism
What is Deep Vein Thrombosis (DVT)? DVT is the formation of a blood clot (thrombus) within a deep vein. The deep veins pass through deep tissues and muscles. Muscle contractions (walking, running, activity, etc.) squeeze blood through the deep veins to the heart. The deep veins have valves which prevent blood from flowing back to the ankles and feet. The majority of blood clots are small and are usually broken down or dissolved. Large clots may form and can block the vein causing the patient to complain of pain and swelling. Homan's sign is not very specific. High index of suspicion is necessary for diagnosis. Virchow'...
Source: Healthy Living - The Huffington Post - August 17, 2016 Category: Consumer Health News Source Type: news

New study reveals warfarin may be ineffective for atrial fibrillation over long-term
A study conducted by US-based Duke Clinical Research Institute researchers has revealed that warfarin, a drug prescribed to prevent strokes in patients with atrial fibrillation, may not be able to adequately control long-term blood clotting. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 11, 2016 Category: Pharmaceuticals Source Type: news

Long-Term Warfarin Stability Elusive
(MedPage Today) -- Registry challenges common reason for not switching to NOACS (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 10, 2016 Category: Cardiology Source Type: news

Warfarin Use May Not Bring Long-Term Stability for Atrial Fibrillation
Contact: Amara Omeokwe Phone: 919-681-4239 Email:amara.omeokwe@duke.eduhttps://www.dukehealth.orgEMBARGOED FOR RELEASE until 11 a.m. (ET) on Tuesday, Aug. 9, 2016DURHAM, N.C. -- Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood clotting over the long-term, even when patients have been historically stable on the drug, according to a study from the Duke Clinical Research Institute.The findings, published Aug. 9 in the Journal of the American Medical Association (JAMA), are based on an 18-month study of 3,749 patients diagnosed with atrial fibrillation, an irregular heart rhythm. T...
Source: DukeHealth.org: Duke Health Features - August 9, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

Warfarin INR Instability Common, Supports Shift to NOACs: Study Warfarin INR Instability Common, Supports Shift to NOACs: Study
At least a third of patients on warfarin had INR values that were off, not"just slightly out of range" but"significantly out of range," an author says.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 9, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

warfarin (Coumadin, Jantoven)
Title: warfarin (Coumadin, Jantoven)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 8/5/2016 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - August 5, 2016 Category: Cardiology Source Type: news

Apixaban 5 mg ‘appropriate’ in AF patients with one dose-reduction criterion
The benefits of apixaban 5 mg over warfarin are maintained in patients with atrial fibrillation who are of advanced age, have low body weight or elevated creatinine levels, analysis of ARISTOTLE data shows. (Source: MedWire News)
Source: MedWire News - July 29, 2016 Category: Consumer Health News Tags: Arrhythmia Source Type: news

Treatment with Pradaxa < sup > ® < /sup > associated with better patient outcomes after a major bleeding event compared to warfarin
Treatment with Pradaxa ® associated with better patient outcomes after a major bleeding event compared to warfarin (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news

Better outcome in case of major bleed for patients taking the anticoagulant Pradaxa < sup > ® < /sup > compared to warfarin
Better outcome in case of major bleed for patients taking the anticoagulant Pradaxa ® compared to warfarin (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news

Pradaxa < sup > ® < /sup > (dabigatran etexilate) 150mg bid continues to be the only oral anticoagulant which showed superior ischaemic stroke reduction vs. warfarin in its pivotal study RE-LY < sup > ® < /sup > – Results of the ENGAGE AF-TIMI 48 trial published for edoxaban vs. warfarin do
Pradaxa ® (dabigatran etexilate) 150mg bid continues to be the only oral anticoagulant which showed superior ischaemic stroke reduction vs. warfarin in its pivotal study RE-LY ® – Results of the ENGAGE AF-TIMI 48 trial published for edoxaban vs. warfarin do (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news

ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa < sup > ® < /sup > on kidney function over time compared to warfarin
ESC Congress 2014 Hot Line Session: Favourable effect of Pradaxa ® on kidney function over time compared to warfarin (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news

Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa < sup > ® < /sup > than with warfarin
Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa ® than with warfarin (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news

Get Rid of Toxins to Reduce Risk of Stroke
Effects of Toxins I’ve been warning you about the toxins in our environment for years. They cause inflammation… They make you gain weight… They cause you to feel fatigued… Our exposure to them starts before we’re even born. One study found 287 chemicals and toxins in the blood of newborn babies.1 It’s shocking. What is in the air we breathe? We breathe in toxins and air pollutants every day. Carbon dioxide, lead, nitrogen oxide, sulfur dioxide, and particulate matter (PM). Causes of Stroke Now, a new study reveals that air pollution is responsible for as many as one-third of all strok...
Source: Al Sears, MD Natural Remedies - July 15, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news

The Participatory Approach to Personalized Medicine
Realizing personalized medicine’s full benefits will require active patient involvement. This is the first in a series of articles defining personalized medicine in the context of participatory medicine. The series will explore how current best practices can contribute to improved medical outcomes, reduced medication adverse reactions, increased patient satisfaction and overall value. What is “personalized medicine?” Personalized medicine, which is also called precision or individualized medicine, is an evolving field in which physicians use certain diagnostic tests to determine which medical treatments w...
Source: Society for Participatory Medicine - July 14, 2016 Category: Journals (General) Authors: John Hoben Tags: Newsletter biomarkers individualized medicine participatory approach Patient Involvement personalized medicine Source Type: news

CardioBrief: Warfarin Monitoring System Cited in Controversy Withdrawn
(MedPage Today) -- FDA says manufacturer has not demonstrated that it has fixed the problem (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 13, 2016 Category: Cardiology Source Type: news

LAA Interventions No Better Than Long-Term Warfarin (CME/CE)
(MedPage Today) -- Meta-analysis pans evidence for devices, surgery (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 12, 2016 Category: Cardiology Source Type: news

Alere withdraws INRatio monitors from U.S. market
Alere (NYSE:ALR), in collaboration with the FDA, said today that it is voluntarily withdrawing its INRatio and INRatio 2 PT/INR monitoring systems designed to monitor blood flow and clotting. The company said it is working with the federal watchdog to “determine the most appropriate timing for product discontinuation” and said it will “provide guidance” to aid patients transitioning to alternative anti-coagulation monitoring systems in the “least disruptive way possible.” In 2014, Alere initiated a voluntary correction informing users of the INRatio systems that patients with &ldquo...
Source: Mass Device - July 12, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Recalls Alere Source Type: news

CardioBrief: Core Lab Data Corroborates ROCKET AF Results
(MedPage Today) -- Test of stored blood may further ease concerns about warfarin tests in trial (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 7, 2016 Category: Cardiology Source Type: news

Apologizing for medical errors
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 7, 2016 Category: Endocrinology Source Type: news

Apologizing for medical errors
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Pediatric News)
Source: Pediatric News - July 7, 2016 Category: Journals (General) Source Type: news

Apologizing for medical errors
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 7, 2016 Category: Neurology Source Type: news

Apologizing for medical errors
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Family Practice News)
Source: Family Practice News - July 7, 2016 Category: Primary Care Source Type: news

Medical errors and the law
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 7, 2016 Category: Endocrinology Source Type: news

Medical errors and the law
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Pediatric News)
Source: Pediatric News - July 7, 2016 Category: Journals (General) Source Type: news

Medical errors and the law
Question: A patient was admitted with heart failure, developed deep vein thrombosis, and was started on warfarin and Lovenox as “bridge” therapy. On day 4, the patient achieved anticoagulation... (Source: Clinical Neurology News)
Source: Clinical Neurology News - July 7, 2016 Category: Neurology Source Type: news

Little Extra Bleed Risk With Warfarin in Elderly Patients
(MedPage Today) -- Clot risk rises more than bleeding risk after age 80 in real-world data (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 5, 2016 Category: Cardiology Source Type: news

Effectiveness and Safety of NOACs vs. Warfarin in AFEffectiveness and Safety of NOACs vs. Warfarin in AF
How does the effectiveness and safety of dabigatran, rivaroxaban, and apixaban compare with warfarin when used for patients with atrial fibrillation in a routine care setting? British Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 1, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Jun 24 Cardiology NewsJun 24 Cardiology News
Insulin-Statin-PCSK9 linkage, QOL on warfarin, ticagrelor adherence, cardio-protection for Breast CA Rx, Brugada Syndrome and AF ablation as a placebo are discussed by Dr Mandrola in this week's podcast. theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 24, 2016 Category: Cardiology Tags: Cardiology News Source Type: news